Bladder Cancer

Standard of care for the detection bladder cancer is cytological evaluation of cell morphology and the FDA approved UroVysion assay.

 

FISH Assays:

Aneuploidy:  Copy number increases of chromosomes 3, 7, and 17 are associated with bladder cancer.

p16 (9p21): Deletion of 9p21 (p16) is associated with bladder cancer.

 
Order FISH Probes
 

References

1. Skacel M, Fahmy M, Brainard JA, Pettay JD, Biscotti CV, Liou LS, Procop GW, Jones JS, Ulchaker J, Zippe CD, Tubbs RR.: Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol. 2003 Jun;169(6):2101-5.